Christopher Griffiths - Selected Publications#

513 Publications H-Index: 79 Web of Science; 92 Google Scholar.

Griffiths CEM, Powles AV, Leonard JN, Baker BS, Fry L, Valdimarsson H: Clearance of psoriasis with low dose cyclosporin. Br Med J 1986; 293:731-732

Griffiths CEM, Voorhees JJ, Nickoloff BJ. Characterization of intercellular adhesion molecule-1 and HLA-DR in normal and inflamed skin: modulation by recombinant interferon and tumor necrosis factor. J Am Acad Dermatol 1989; 20:617-629

Griffiths CEM, Nickoloff BJ. Keratinocyte intercellular adhesion molecule-1 (ICAM-1) expression precedes dermal T lymphocytic infiltration in allergic contact dermatitis (Rhus dermatitis). Am J Pathol 1989; 135:1045-1054

Griffiths CEM, Russman AN, Majmudar G, Singer RS, Hamilton TA, Voorhees JJ. Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid). N Eng J Med 1993; 329:530-535

Young HS, Summers AM, Bhushan M, Brenchley PEC, Griffiths CEM. Single Nucleotide Polymorphisms of Vascular Endothelial Growth Factor (VEGF) in Psoriasis of Early Onset. J Invest Dermatol 2004; 122: 209-215

Cumberbatch M, Singh M, Dearman RJ, Young HS, Kimber I, Griffiths CEM. Impaired Langerhans’ cell migration in psoriasis. J Exp Med 2006; 203:953-60

Reich K, Nestle FO, Papp K, Ortonne JP, Evans R, Guzzo C, Li S, Dooley LT, Griffiths CEM. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double blinded trial. Lancet 2005; 366: 1367-74

Griffiths CEM, Barker JNWN. Pathogenesis and clinical features of psoriasis. Lancet 2007; 370: 263-271

Griffiths CEM,Strober B,van de Kerkhof P, HoV, Fideluis-GortR, Yielding N, Guzzo C,Xia Y, Zhou B,Lii S, Dooley LT, Goldstein NH, Menter AM Comparison of ustekinumab and etanercept for the treatment of moderate to severe psoriasis. N Eng J Med; 2010; 362: 118-28

Rook's Textbook of Dermatology 7th, 8th and 9th editions, co-editor now senior editor. World's leading textbook of dermatology.